Clinical trials are essential for testing new treatments and therapies. Recent updates have streamlined the clinical trial process, making it more efficient and patient-centric. Adaptive clinical trials allow for modifications based on interim results, accelerating the evaluation of new treatments. Moreover, there is a growing emphasis on patient participation and diversity, ensuring that trials reflect the broader population affected by cancer.
